A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study of Mitapivat in Patients with Sickle Cell DiseaseJoanna Howard, Swee Lay Thien, Abdulafeez Oluyadi et al.|Blood|2021Cited by 4